PEBC Report - Programa de Epigenética y BiologÃa del Cáncer
PEBC Report - Programa de Epigenética y BiologÃa del Cáncer
PEBC Report - Programa de Epigenética y BiologÃa del Cáncer
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Foreword by Emilià Pola,<br />
IDIBELL General Director<br />
T<br />
he Bellvitge Biomedical Research Institute – IDIBELL is an emerging<br />
research institution where medicine meets with research for a<br />
better un<strong>de</strong>rstanding of patients needs and diseases of all sorts. With<br />
a <strong>de</strong>dicated team of more than 500 researchers, IDIBELL has a committment<br />
to address relevant clinical problems to bring about significant<br />
improvements in health an quality of life. Our research is based<br />
on the activity of the two partner hospitals (Bellvitge University<br />
Hospital and Catalan Institute of Oncology) and consequently has a<br />
very wi<strong>de</strong> scope, ranging from epi<strong>de</strong>miology to infectious diseases,<br />
organ transplantation and immunology, human genetics, neurology,<br />
metabolic diseases and cancer in its very diverse forms.<br />
The Cancer Epigenetics and Biology Program (<strong>PEBC</strong>) is the most<br />
recent addition to our the scientific activity, and helps to keep IDIBELL<br />
at the forefront of global biomedical research. The emerging discipline<br />
of epigenetics is ushering in a new paradigm that significantly<br />
expands our un<strong>de</strong>rstanding of genes and their interaction with the environment, shedding new light<br />
on many biological and medical challenges.<br />
It is for me a pleasure and a privilege to host the symposium and to welcome you all to this exciting<br />
opportunity to discuss and to participate in one of the hottest and most rapidly <strong>de</strong>veloping fields<br />
of mo<strong>de</strong>rn biology and medicine.<br />
Emilià Pola<br />
General Director IDIBELL<br />
Cancer Epigenetics and Biology Symposium<br />
4 28, 29 May 2009, Barcelona